These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21617544)

  • 21. Long-term treatment with probiotics in primary care patients with irritable bowel syndrome--a randomised, double-blind, placebo controlled trial.
    Begtrup LM; de Muckadell OB; Kjeldsen J; Christensen RD; Jarbøl DE
    Scand J Gastroenterol; 2013 Oct; 48(10):1127-35. PubMed ID: 23957590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics and functional gastrointestinal disorders in children.
    Vandenplas Y; Benninga M
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S107-9. PubMed ID: 19300120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation of the microbiota and intestinal mucosa in the pathophysiology and treatment of irritable bowel, irritable eye, and irritable mind syndrome].
    Fehér J; Kovács I; Pacella E; Radák Z
    Orv Hetil; 2014 Sep; 155(37):1454-60. PubMed ID: 25194867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial of probiotics after colonoscopy.
    D'Souza B; Slack T; Wong SW; Lam F; Muhlmann M; Koestenbauer J; Dark J; Newstead G
    ANZ J Surg; 2017 Sep; 87(9):E65-E69. PubMed ID: 26183594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bifidobacterium bifidum MIMBb75 in irritable bowel syndrome.
    Quigley EM
    Aliment Pharmacol Ther; 2011 Jul; 34(1):100-1; author reply 101. PubMed ID: 21631550
    [No Abstract]   [Full Text] [Related]  

  • 26. The rationale and clinical effectiveness of probiotics in irritable bowel syndrome.
    Ringel Y; Ringel-Kulka T
    J Clin Gastroenterol; 2011 Nov; 45 Suppl():S145-8. PubMed ID: 21992954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Probiotic supplement (Lactobacillus acidophilus and bulgaricus) utility in the treatment of irritable bowel syndrome].
    Diaz Ferrer J; Parra V; Bendaño T; Montes P; Solorzano P
    Rev Gastroenterol Peru; 2012; 32(4):387-93. PubMed ID: 23307089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotic bacteria: safety, functional and technological properties.
    Saarela M; Mogensen G; Fondén R; Mättö J; Mattila-Sandholm T
    J Biotechnol; 2000 Dec; 84(3):197-215. PubMed ID: 11164262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure to define what constitutes a patient responder is a problem in the interpretation of the probiotic clinical trial evaluating the use of Bifidobacterium in irritable bowel syndrome.
    van Zanten SV
    Gastroenterology; 2005 Aug; 129(2):772; author 772-3. PubMed ID: 16083745
    [No Abstract]   [Full Text] [Related]  

  • 31. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention.
    Kajander K; Hatakka K; Poussa T; Färkkilä M; Korpela R
    Aliment Pharmacol Ther; 2005 Sep; 22(5):387-94. PubMed ID: 16128676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium animalis subsp. lactis Bi-07.
    Larsen N; Vogensen FK; Gøbel R; Michaelsen KF; Abu Al-Soud W; Sørensen SJ; Hansen LH; Jakobsen M
    FEMS Microbiol Ecol; 2011 Mar; 75(3):482-96. PubMed ID: 21204871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irritable bowel syndrome and probiotics: from rationale to clinical use.
    Verdu EF; Collins SM
    Curr Opin Gastroenterol; 2005 Nov; 21(6):697-701. PubMed ID: 16220048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics for irritable bowel syndrome: should we give them full names?
    Álvarez-Sánchez Á; Rey E
    Rev Esp Enferm Dig; 2013 Jan; 105(1):1-2. PubMed ID: 23548003
    [No Abstract]   [Full Text] [Related]  

  • 35. Editorial: probiotics and IBS - where are we now?
    Moran C; Shanahan F
    Aliment Pharmacol Ther; 2014 Aug; 40(3):318. PubMed ID: 25040745
    [No Abstract]   [Full Text] [Related]  

  • 36. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.
    Dughera L; Elia C; Navino M; Cisarò F;
    Acta Biomed; 2007 Aug; 78(2):111-6. PubMed ID: 17933278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome.
    Zeng J; Li YQ; Zuo XL; Zhen YB; Yang J; Liu CH
    Aliment Pharmacol Ther; 2008 Oct; 28(8):994-1002. PubMed ID: 18671775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review.
    Moraes-Filho JP; Quigley EM
    Arq Gastroenterol; 2015 Dec; 52(4):331-8. PubMed ID: 26840477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of probiotic fermented milk on symptoms and intestinal flora in patients with irritable bowel syndrome: a randomized, placebo-controlled trial.
    Søndergaard B; Olsson J; Ohlson K; Svensson U; Bytzer P; Ekesbo R
    Scand J Gastroenterol; 2011 Jun; 46(6):663-72. PubMed ID: 21443416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.